Immunotherapy aims to treat disease through activation or suppression of an immune response. For example activating immunotherapies can target cancer and suppressive immunotherapies can target autoimmunity.
PD-1 inhibitors include pembrolizumab and nivolumab.
PD-L1 inhibitors include atezolizumab, avelumab, and durvalumab.